Elahera contains Mirvetuximab Soravtansine-gynx, 100mg/20ml, supplied as injection. Manufacturer: ImmunoGen. Therapeutic class: ADC – Ovarian Cancer.
Prescription-only medicine. Supplied against a named-patient prescription, or to holders of a valid drug import or wholesale licence in the destination country.
For indications, dosing and safety information, refer to the approved product label in the prescriber’s country.